PCSK9 targets important for lipid metabolism

Ischemic heart disease is the main cause of death worldwide and it is accelerated by increased low-density lipoprotein (LDL) cholesterol (LDL-C) and/or lipoprotein (a) (Lp(a)) concentrations. Proprotein convertase subtilisin/kexin type 9 (PCSK9) alters both LDL-C and in part Lp(a) concentrations thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Rainer, Schlüter, Klaus-Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352789/
https://www.ncbi.nlm.nih.gov/pubmed/28176216
http://dx.doi.org/10.1007/s11789-017-0085-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352789/
https://www.ncbi.nlm.nih.gov/pubmed/28176216
http://dx.doi.org/10.1007/s11789-017-0085-0

Ejemplares similares